Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/postgradmedj-2020-138756 http://scihub22266oqcxt.onion/10.1136/postgradmedj-2020-138756 32913038!10016911!32913038     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Postgrad+Med+J 2021 ; 97 (1148): 380-383 Nephropedia Template TP {{tp|p=32913038|t=2021. Is HbA1c an ideal biomarker of well-controlled diabetes?|pdf=|usr=}}{{32913038}} gab.com Text Is HbA1c an ideal biomarker of well-controlled diabetes JO: Postgrad Med J http://www.kidney.de/pget.php?&tw=1&pmid=32913038 #FOAvip HbA1c is a biomarker with a central role in the diagnosis and follow-up of patients with diabetes, although not a perfect one. Common comorbidities encountered in patients with diabetes mellitus, such as renal insufficiency, high output states (iron deficiency anaemia, haemolytic anaemia, haemoglobinopathies and pregnancy) and intake of specific drugs could compromise the sensitivity and specificity of the biomarker. COVID-19 pandemic poses a pressing challenge for the diabetic population, since maintaining optimal blood glucose control is key to reduce morbidity and mortality rates. Alternative methods for diabetes management, such as fructosamine, glycosylated albumin and device-based continuous glucose monitoring, are discussed. Twit Text FOAVip Is HbA1c an ideal biomarker of well-controlled diabetes ????Postgrad Med J http://www.kidney.de/pget.php?&tw=1&pmid=32913038 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32913038 #FOAvip English Wikipedia <ref>{{Cite pmid|32913038}}</ref> Is HbA1c an ideal biomarker of well-controlled diabetes? #MMPMID32913038 Kaiafa G; Veneti S; Polychronopoulos G; Pilalas D; Daios S; Kanellos I; Didangelos T; Pagoni S; Savopoulos C Postgrad Med J 2021[Jun]; 97 (1148): 380-383 PMID32913038show ga HbA1c is a biomarker with a central role in the diagnosis and follow-up of patients with diabetes, although not a perfect one. Common comorbidities encountered in patients with diabetes mellitus, such as renal insufficiency, high output states (iron deficiency anaemia, haemolytic anaemia, haemoglobinopathies and pregnancy) and intake of specific drugs could compromise the sensitivity and specificity of the biomarker. COVID-19 pandemic poses a pressing challenge for the diabetic population, since maintaining optimal blood glucose control is key to reduce morbidity and mortality rates. Alternative methods for diabetes management, such as fructosamine, glycosylated albumin and device-based continuous glucose monitoring, are discussed. |Biomarkers/blood[MESH] |Blood Glucose Self-Monitoring[MESH] |Blood Glucose/metabolism[MESH] |COVID-19/*complications[MESH] |Diabetes Mellitus, Type 1/blood/*diagnosis[MESH] |Diabetes Mellitus, Type 2/blood/*diagnosis[MESH] |Glycated Hemoglobin/*metabolism[MESH] |Humans[MESH]Is HbA1c an ideal biomarker of well-controlled diabetes?(epmc).pdf DeepDyve Pubget Overpricing